首页> 美国卫生研究院文献>Archives of Medical Science : AMS >LncRNA PCAT-1 upregulates RAP1A through modulating miR-324-5p and promotes survival in lung cancer
【2h】

LncRNA PCAT-1 upregulates RAP1A through modulating miR-324-5p and promotes survival in lung cancer

机译:LNCRNA PCAT-1通过调节miR-324-5p来提高RAP1A并促进肺癌的存活

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancer is the malignant tumor with the fastest increase in morbidity and mortality and the greatest threat to human health and life. Long non-coding RNA (lncRNA) is emerging as an important regulator in many cancers. Recently, it was found that lncRNA prostate cancer associated transcript 1 (PCAT-1) was up-regulated in lung cancer, playing oncogenic roles. However, the underlying regulatory mechanism of PCAT-1 remains unknown.
机译:肺癌是恶性肿瘤,发病率和死亡率最快,对人类健康和生活的最大威胁。长期非编码RNA(LNCRNA)在许多癌症中作为重要调节剂。最近,发现LNCRNA前列腺癌相关的转录物1(PCAT-1)在肺癌中调节,起致癌作用。然而,PCAT-1的潜在监管机制仍然未知。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号